China could overtake the U.S. in brain computer interface (BCI) technology leadership in the coming months/years, thanks to a fortunate mix of government support and investor enthusiasm. In a recent interview with the Financial Times (FT), Tiger Tao, the founder of Shanghai-based NeuroXess, highlighted the rapid progress of the firm’s BCI technology. NeuroXess (no relation to Intel XeSS) was set up in 2021 and has already reported some successful human BCI trials.
The FT report comes less than six months after we covered news of China’s plans to outpace Neuralink with a state-backed BCI blitz, to coin a phrase.
